An opioid made in the brain is crucial for remembering others
It would be inconvenient if we couldn’t remember the people we have or haven’t met before. Social recognition, the ability to differentiate familiar or novel individuals of the same species is part of a larger process of social memory that allows groups within a species to build and maintain stable networks or relationships, like what we know as friend groups or communities.

The hippocampus, known for its role in memory, is divided into subregions that contribute to different memory processes, and one called CA2 is particularly important for social memory. Scientists have found one particular neurochemical to be important in social recognition. Enkephalin, a neuropeptide that interacts with opioid receptors, is needed in CA2 to recognize new people.
Enkephalins belong to a class of opioids produced by the brain which are often associated with stress response and pain relief. The researchers found that in CA2, these compounds are released by specific type of neuron, boosting information transfer to the CA2, thus enabling our brains to form social memories.
Scientists studied the effects of enkephalin through a social memory test in mice. They introduced one mouse to a space with two others, and the subject mouse was allowed to interact with each mouse for fiver minutes. The subject mouse was removed, then returned half an hour later, this time with one of the mice from the last entry and one mouse it had not met before. The typical response for mice in this case is to pay attention to the new mouse for longer. The scientists observed that, while mice with regular enkephalin levels sniffed out the new mouse for a longer amount of time, mice without enkephalin spent the same amount of time between both mice, as if they had not previously encountered one of them.
A better understanding of social memory can help demystify related diseases. Schizophrenia, a condition in which social memory is impaired, is treated with drugs affecting opioid receptors, for example. The results of this study shed light on how these treatments work.
This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.

Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.

AI unlocks the hidden grammar of gene regulation
Using fruit flies and artificial intelligence, Julia Zeitlinger’s lab is decoding genome patterns — revealing how transcription factors and nucleosomes control gene expression, pushing biology toward faster, more precise discoveries.